Whiteside O J H, Martinez Devesa P, Ali I, Capper J W R
Department of Otolaryngology, Radcliffe Infirmary, Oxford, UK.
J Laryngol Otol. 2003 Nov;117(11):885-8. doi: 10.1258/002221503322542917.
Mucous membrane pemphigoid (MMP) is a sub-epithelial blistering disease that primarily involves mucosal surfaces but may also involve the skin. Clinically, it appears as vesiculobullous lesions of the oral cavity and eyes, but other tissues such as the nasopharyngeal and laryngeal mucosa can also be affected. Ultimately, scarring and airway stenosis may occur. The condition should be managed by a multidisciplinary team led by a dermatologist. Immunosuppressive therapy forms the mainstay of treatment, with surgery having both a diagnostic role and a use in the treatment of complications such as airway obstruction. There must be a low threshold of suspicion for laryngeal involvement in this group of patients, so that prompt action can be taken. Once laryngeal stenosis has occurred repeated endoscopic laser excision of scar tissue can be used to maintain an adequate airway. Adjuvant use of mitomycin-C can be used beneficially in the treatment of laryngeal complications of MMP.
黏膜类天疱疮(MMP)是一种上皮下疱性疾病,主要累及黏膜表面,但也可能累及皮肤。临床上,它表现为口腔和眼部的水疱大疱性病变,但鼻咽和喉黏膜等其他组织也可能受累。最终,可能会出现瘢痕形成和气道狭窄。该病应由皮肤科医生领导的多学科团队进行管理。免疫抑制治疗是主要的治疗方法,手术具有诊断作用,并可用于治疗气道阻塞等并发症。对于这类患者,必须对喉部受累保持较低的怀疑阈值,以便能够迅速采取行动。一旦发生喉狭窄,可反复进行内镜下激光切除瘢痕组织以维持足够的气道。辅助使用丝裂霉素-C可有效治疗MMP的喉部并发症。